United States Prostate Cancer Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Blue Earth Diagnostics, Inc., Telix Pharmaceuticals (US) Inc., Pfizer Inc., Astellas Pharma US, Inc., Sanofi-Aventis U.S. LLC., Genentech USA

Prostate Cancer Market is projected to grow from US$ 13.22 billion in 2024 to US$ 28.10 billion by 2033, registering a CAGR of 7.8% during the forecast period.

DataM Intelligence has published a new research report on "Prostate Cancer Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/prostate-cancer-market?sg

Key Players: Bayer AG, Johnson & Johnson, Novartis Pharmaceuticals Corporation, Blue Earth Diagnostics, Inc., Telix Pharmaceuticals (US) Inc., Pfizer Inc., Astellas Pharma US, Inc., Sanofi-Aventis U.S. LLC., Genentech USA, Inc., Pfizer Inc., AstraZeneca, and Eli Lilly Inc.

Industry Latest News 2025

✅ 2025-06-03 - FDA approves darolutamide (Nubeqa) for metastatic castration-sensitive prostate cancer (mCSPC) - indication expansion for the androgen-receptor inhibitor.

✅ 2025-03-21 - FDA approves Gozellix® (Telix) - a new 68Ga PSMA-PET imaging agent for detection of PSMA-positive lesions (initial definitive therapy and suspected recurrence).

✅ 2025-03-20 / 2025-03-21 - Regulatory/companion kit approved for Telix imaging (TLX007-CDx / cold kit) - support product for preparing PSMA-PET imaging with extended distribution/shelf profile.

✅ 2025-01-08 - Roche completes acquisition of Poseida Therapeutics (~$1.5B) - strategic oncology / cell-therapy acquisition that strengthens Roche's cancer therapy pipeline (deal closed in early-2025).

✅ 2025-08-06 - FDA accepts NDA for a new F-18 formulation of piflufolastat (Pylarify) - Lantheus' application acceptance moves another PSMA PET product toward broader availability (PDUFA/target action date set).

✅ 2025-08-19 - Teleflex launches BarrigelTM rectal spacer in Japan - commercial rollout of a hyaluronic-acid rectal spacer to reduce radiation-therapy rectal toxicity for prostate radiotherapy patients.

Growth Forecast Projected:

The Global Prostate Cancer Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Prostate Cancer Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=prostate-cancer-market?sg

Key Segments:

By Therapy (Chemotherapy, Hormonal Therapy, Immunotherapy, Targeted Therapy)

By Routes of Administration (Intravenous, Oral Route, Other Routes)

By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacies)

By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Prostate Cancer producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Prostate Cancer revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/prostate-cancer-market?sg

FAQ's

Q1: What is the current size of the Prostate Cancer Market?

A: The Prostate Cancer Market stood at US$ 13.22 billion in 2024 and is set to experience remarkable growth, reaching US$ 28.10 billion by 2033

Q2: How fast is the Prostate Cancer Market growing?

A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 7.8% from 2025-2033

Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/prostate-cancer-market?sg

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.